When AI Steps Back, Care Steps Forward: A Pilot Implementation Study on AI Agent Deployment and Clinician Time Recovery

Abstract 

Administrative burden now consumes approximately 40% of a clinician's working day. This pilot implementation study examines the structured deployment of AI agents by Nova Insights Corp across health system settings in the United States, Canada, and the European Union. Using pre-deployment workflow time-mapping as a baseline, the study documents outcomes across patient scheduling, consult preparation, multidisciplinary team coordination, post-discharge outreach, and surgical readiness workflows. AI agents achieved automation rates of 96–99%, recovering thousands of clinician hours annually per site. Day-of-surgery cancellations fell from 17% to under 2%. At a U.S. Veterans Health Administration site, 30-day readmissions dropped from 11% to near zero. Return on investment ranged from 148% to 965%. These results demonstrate intelligent automation, applied with workflow fidelity, can materially restore clinical time, reduce operational waste, and improve downstream patient outcomes.

Keywords: AI agents, administrative burden, clinician time recovery, physician burnout, intelligent automation, healthcare workflow redesign

Introduction

Clinicians in North America and Europe now spend an estimated 40% of their working hours on administrative tasks. Documentation, scheduling, pre-visit chart preparation, post-discharge outreach, and coordination work consume the majority of a physician’s non-patient time and increasingly, their patient time as well. In a standard 15-minute appointment, up to 14 minutes may be spent navigating charts, retrieving lab results, and reconciling fragmented records, leaving barely 60 seconds for genuine clinical engagement.

Technology, paradoxically, has compounded this problem. The widespread adoption of electronic health record (EHR) systems, along with documentation obligations due to the regulatory requirements within the adoption of EHRs such as Meaningful Use, created new documentation obligations alongside the data-access benefits they were designed to deliver. The result is a workforce structurally unable to spend its time on the work it was trained to do.

This paper is not about AI as it is popularly imagined as, being diagnostic systems, predictive models, or autonomous decision-makers. It is about a more immediate and flexible application: using AI agents to perform the structured, repetitive administrative tasks currently occupying a clinician’s attention. Not to replace clinical judgment, but to remove the friction surrounding it. The question this study addresses is straightforward: how much clinical time can be recovered, and what happens to care when it is?

Nova Insights team has deployed AI agents across health system sites in the United States, Canada, and the European Union between 2020 and 2025. This paper documents how baselines were established, how workflows were mapped, what changed after deployment, and what the results mean for health system leaders.

Methods

2.1 Establishing the Baseline

Organizations may say they already have their workflows documented, but there is usually a significant disconnect between what is documented and what is occurring. Employees create workarounds when they are uncertain or find a ‘better’ way to do things and these don’t translate usually to the workflow as initially designed. So, before any agent was designed or built, each deployment began with a structured process assessment. Nova Insights conducted intake sessions with internal process leads at each site, typically 2 to 3 hours of working time from clinical or operational staff, to map existing workflows in granular detail.

For each administrative process under consideration, the assessment documented: every step in the workflow and the role responsible for it; the volume of cases handled annually; the total staff hours consumed; the error or exception rate (incomplete patient records, missing pre-operative labs, unreturned patient contacts); and, where measurable, the downstream clinical consequences of workflow failures such as surgical cancellations or hospital readmissions.

Historically, management has frequently had to rely on anecdotal evidence and/or lacked practice in developing agreed upon baselines. So, to the extent possible, the baseline was documented, quantified, and used as the reference point against which post-deployment outcomes were compared. Without this step, ROI and time-savings claims would not be credible. With a strong benchmark established, the outcomes are verifiable, making this step critical to the pilot’s success and building a strong foundation to take the pilot to scale.

2.2 Workflow Time-Mapping

Following baseline establishment, each administrative workflow was time-mapped: broken into its component steps, with each step assigned a time cost, a decision logic, and a set of exception conditions. This mapping served two purposes. First, it identified where human time was being consumed in ways with the potential to be automated such as data retrieval, record aggregation, form verification, and/or outreach execution. Second, it defined the precise scope of what each AI agent would handle, and what would be escalated to a clinician.

The scope definition was deliberate and constrained. Agents were not designed to make clinical decisions, interpret ambiguous patient presentations, or act outside defined parameters. They were designed to execute specific administrative tasks with high consistency and to flag exceptions for human review. This narrow scope was not a limitation — it was the design choice making 96–99% automation achievable.

Workflows selected for the initial deployment portfolio included:

• Patient scheduling: appointment intake, plan code assignment, waiting list management, confirmations, and lab request coordination

• Consult preparation and charting: pre-visit aggregation of lab results, radiology, pathology, microbiology, medication records, and prior appointment outcomes

• Multidisciplinary team (MDT) meeting preparation: patient record compilation and specialist briefing for case review sessions

• Day-of-surgery readiness verification: automated pre-operative patient outreach, form and lab completion verification, at-risk patient flagging

• Post-discharge outreach and 30-day follow-up: automated contact with discharged patients, adherence verification, high-risk indicator detection

2.3 Deployment and Integration

Fundamental to the process was involving key stakeholders affected by these agents. They were critical in helping understand the existing workflows, provided input on what improvements to make and were directly involved in developing and testing flows to ensure the results provided value and did not create additional administrative burden.  The agents designed were integrated directly into existing EHR and related workflows at each site. No parallel infrastructure was built. Clinicians did not adopt new interfaces; they received agent outputs within the systems they were already using. This integration was central to adoption: staff experienced the removal of tasks, not the addition of new platforms.

For the  purposes of this paper, we reviewed the results from five sites located in the United States, the EU and Canada. Implementation followed a six-stage framework: Process Assessment, AI Agent Design, Agile Development, User Acceptance Testing, Go-Live, and Handover, spanning approximately 30 weeks. Clinical staff time commitment was deliberately minimized at each stage, typically 1–2 hours per process lead, to avoid adding implementation burden to already stretched teams.

Through direct discussion with the affected stakeholders, both in-person and digitally, post-deployment measurement was conducted at a minimum of 90 days post-go-live, with ongoing tracking, thereafter, comparing outcomes against the documented baseline for each workflow. The Return On Investment (ROI) was calculated using the base values of hours involved in thew various utilizations, the direct costs/savings associated with those hours, and the cost of the development, implementation and on going management of those specific 0agent (s) in the initial twelve months. 

Results

3.1 Clinician Time Recovery

Across all documented deployments, AI agents attained automation rates of 96–99% on targeted administrative workflows, indicating nearly all targeted cases were processed end-to-end without human intervention. The table below summarizes primary outcomes by use case:

Use Case

Annual Cases

Hrs Saved / Year

Automation Rate

ROI

Patient Scheduling

20,800

1,740

96%

495%

ConsultPrep / Charting

7,027

2,297

99%

965%

MDT Meeting Preparation

4,800

784

99%

148%

Radiology Image Importing

72,000

2,520

99%

573%

Emergency Dept. Coding

19,500

683

97%

430%

The cumulative picture is meaningful. A health system deploying agents across even a subset of these use cases recovers the equivalent of multiple full-time administrative positions in clinical capacity annually. 

The appointment-level impact is equally telling. Prior to deployment, a standard 15-minute patient visit consumed up to 14 minutes in chart navigation and data retrieval. After deployment of pre-visit AI preparation agents, the ratio inverted: clinicians reported spending approximately 14 minutes in direct patient interaction and 1 minute on record review. The human moment at the center of the appointment was restored.

3.2 Day-of-Surgery Cancellation Reduction

Day-of-surgery (DOS) cancellations represent one of the most operationally expensive failure modes in surgical care: unused operating room time, rescheduling burden, and, critically, patients arriving unprepared for procedures they have been anticipating. Cancellations are frequently caused by patients missing required pre-operative tests, not having followed pre-surgical instructions, or presenting with unresolved conditions that could have been identified and addressed in advance.

AI agents addressed each of these root causes directly, automating pre-operative patient communication, verifying completion of required labs and forms, and flagging at-risk patients for clinical follow-up before the procedure date. The result was a reduction in cancellation rates from 17% to under 2% sustained across deployment sites.

Metric

Baseline

Post-Deployment

Day-of-Surgery Cancellation Rate

Up to 17%

Under 2%

Pre-Op Instruction Compliance

Variable / manual

Automated, verified

Clinician-to-Patient Contact Ratio

1:25

1:125 (+500%)

3.3 Post-Discharge Outreach and Readmission Reduction

Of clinical importance in this study was observed at a Veterans Health Administration facility in the United States, where AI agents were deployed to manage post-discharge health survey administration and 30-day follow-up outreach.

Prior to deployment, post-discharge survey administration consumed 172 staff hours per cycle. Following AI agent implementation, post-discharge survey administration dropped to 2 hours for a 98.8% reduction. The agent did not make clinical decisions. It ensured patients were reliably contacted, medication adherence and appointment follow-through were verified, and high-risk indicators such as missed medications, unreported symptoms, and social needs were flagged for clinical intervention before they could escalate to readmission.

As to Clinical/Patient Management, in one facility’s women’s health area, prior to utilization of our solution, the operating ratio was 1 clinician to 25 women patients, following implementation, they were able to adjust the management ratio to 1 clinician to 125 women, while improving outcomes and satisfaction scores.

Metric

Baseline

Post-Deployment

30-Day Readmission Rate

11%

~0% (1 patient)

7-Day Follow-Up No-Shows

30%

7%

Substance Use Disorder Relapse

30%

13%

Post-Discharge Survey Admin Hours

172 hrs

2 hrs

HEDIS Outreach Cost vs. Call Center

Confidential

Reduced cost by 65%

Contact Completion Rate vs. Call Center

Confidential

Improved Completion +200%

The financial case is equally direct. Avoiding a single bed-night per month was sufficient to offset the total monthly cost of the AI Agent service. In practice, one of our clients documented avoiding an estimated $1.37 million in admission costs over one year.

Discussion

4.1 What the Results Mean for Healthcare Leaders

The data in this study does not describe a pilot program built under ideal conditions. It describes outcomes from operational deployments across different national health systems, different EHR environments, and different clinical specialties. The consistency of the core finding across the diverse environment mix is what makes it of strategic relevance: when AI agents are properly scoped and deployed against mapped administrative workflows, they reliably recover clinical time and produce measurable downstream operational improvement.

The implication for health system leaders is direct. Administrative burden is not a fixed cost of healthcare delivery. Undue administrative burden is an outcome of the accumulated weight of structurally inefficient processes designed for a pre-digital era not having yet been systematically redesigned. Inefficiency is addressable with current technology, at manageable cost, with rapid and verifiable return. The barrier to getting started, in most organizations, is not simply a technical blocker. For many organizations, getting started is trying to determine where an AI ‘pilot’ or ‘project’ falls within the very large number of other organizational priorities. What many do not consider are the associated costs of not going forward with a solution to address these issues.

4.2 The Conditions for Success

The Agent deployments achieving the highest automation rates and ROI shared a set of implementation characteristics worth naming explicitly, because they are replicable:

• Workflow mapping before agent design. Agents built against vague administrative categories underperform. Agents built against documented, step-mapped processes with defined exception logic achieve 96–99% automation.

• Integration with existing systems. Requiring clinical staff to adopt new platforms is a common failure mode. Agents delivering output into the EHR systems already in use eliminate this friction entirely.

• Constrained scope. The temptation to expand agent scope during deployment is real and should be resisted. Agents with tightly defined responsibilities are more reliable, easier to validate, and faster to trust.

• Minimal staff burden during implementation. Deployment timelines were structured to require 1–2 hours of clinical process lead time per stage. A deployment burning out the clinical team during implementation has already failed.

• Measured from day one. Without a documented baseline, post-deployment claims are anecdote. With one, they are evidence. This distinction matters for institutional buy-in and for ongoing system improvement.

4.3 A Note on AI vs. Automation

Not every administrative problem requires artificial intelligence to solve. The deployments documented here used AI capabilities — natural language processing, pattern recognition, multi-source data aggregation — where those capabilities added genuine value. In other workflows, simpler rule-based automation was the right tool and was used accordingly.

Health system leaders should resist the pressure to deploy AI for its own sake. The relevant question is not “can we use AI here?” It is “what administrative problem needs solving, and what is the most reliable and cost-effective way to solve it?” Sometimes the answer is AI. Sometimes it is better process design. The goal is clinician time recovery, not technology deployment.

4.4 Security, Compliance, and Adoption

Three concerns most commonly arise in health system AI adoption conversations: data security, regulatory compliance, and clinical staff adoption. 

On security: the deployments documented here operated with patient data resident on client servers, encrypted access controls, and compliance with ISO27001, NIST 7510, GDPR, and HITRUST standards. Data did not leave the health system environment.

On adoption: because agents were integrated into existing workflows rather than replacing them or working outside of them, clinical staff resistance was minimal. The experience of deployment, for most clinicians, was the gradual disappearance of tasks they found burdensome and not the introduction of a new system they were required to learn. This critical distinction is a meaningfully different adoption dynamic.

On cost and ROI: the financial threshold for cost neutrality is lower than most leaders expect. In the post-discharge program, avoiding a single readmission per month covered the full monthly service cost. In scheduling automation, an ROI of 495% was documented. The financial case does not require large-scale transformation to be compelling; it holds at the level of a single well-scoped use case.

Conclusion

The evidence presented in this study is not theoretical. It is drawn from operational deployments in real health systems, measured against well-defined, documented baselines, and sustained across multiple sites and national contexts. Demonstrating AI agents can do more than automate discrete administrative tasks, they can return time to clinicians, reduce operational waste, and improve the reliability of care delivery. AI agents, when deployed with implementation discipline, reliably achieved 96–99% automation of targeted administrative workflows, recovered thousands of clinical hours annually, reduced day-of-surgery cancellations from 17% to under 2%, and, in one post-discharge program, eliminated 30-day readmissions to near zero.

The larger conclusion is clear. Administrative burden is not an unavoidable condition of modern healthcare. It is a solvable design problem, and the combination of disciplined workflow assessment, constrained agent scope, stakeholder involvement, and measurable implementation provide a practical path forward. The necessary technology exists, the methodology is clearly defined, and the demonstrated financial case is well established. What the results of this study make clear is the question is no longer whether intelligent automation can recover clinical time. The larger question is how long health system leaders can afford to ignore the untapped potential instead of choosing to act on the evidence.

Disclosure

Howard Rosen is Chief Executive Officer of Nova Insights Corp, through which  deployments/results are documented in this study. All quantitative data reflects outcomes from documented client deployments. The author declares no additional conflicts of interest.

Stephanie Hojan is President of Health Systems Informatics (HSi), and not affiliated with Nova Insights Corp. The author declares no additional conflicts of interest.